Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
- Hewlett-Packard Shakes Up Management, Raises Outlook also mentions Management
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- Family Dollar Sees 'Virtual Certainty' Of Antitrust Clearance For Dollar Tree Merger also written by Antoine Gara
- Berkshire Hathaway Wannabe Turning Into A Quagmire For Investors also written by Antoine Gara
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also published in forbes.com
- Why Do Board Directors And CEOs Need To Value UN Sustainability Goal 5 ? - Achieve Gender Equality And Empower All Women And Girls also categorized in BoardMoves
- DuPont Spinoff Fans Flames In Trian Management's Scorched Earth Fight also written by Antoine Gara
Login to comment.